Joint R&D with PeptiDream Inc.Joint R&d Agreement • March 25th, 2016
Contract Type FiledMarch 25th, 2016Asahi Kasei Pharma Corp. (Head office: Chiyoda-ku, Tokyo, Japan; President: Kazuyoshi Hori) and PeptiDream Inc. (Head office: Meguro-ku, Tokyo, Japan; CEO: Kiichi Kubota) have concluded a joint R&D agreement for the discovery and development of nonstandard peptides1 against multiple drug target molecules.